biotech
Welcome to the 'biotech' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'biotech'.
Are you an expert about 'biotech'? Do you want to be the Technorati authority on 'biotech'? You can write a description that will appear right here:
Join Blogcritics!
Original Technorati articles tagged “biotech”
-
in Technology50 Technologies That Will Change the World

A new report reveals over 50 innovations that will drive society in the next 20 years.by cmimanagers / on Nov 23, 2012 -
in BusinessColorado Startup VetDC Targets Biotech Breakthroughs for Pets

Colorado State University Spinoff Signs Licensing Deal for Cancer Drugby johnjegan / on Mar 16, 2011 -
in BusinessPharmaceutical Stocks Expected to Skyrocket in 2011

2011 pharmaceutical stocks to take a look at.by caroline1234 / on Jan 25, 2011
Latest blogosphere posts tagged “biotech”
-
Government Medical College & Hospital Recruitment For Staff Nurse Posts
—
Authority:
Organization Name : Government Medical College & Hospital Job Position : Staff Nurse Pay Scale: Rs.10300-34800/- Eligibility: B Sc, Diploma Job Location : Chandigarh Last Date : 31-05-2013 Hiring Process : Interview.1 week ago -
Bhabha Atomic Research Centre (BARC) Recruitment 2013
—
Authority:
Organization Name : Bhabha Atomic Research Centre (BARC) Job Position : Resident Medical Officer Pay Scale: Rs.40000-44000/- Eligibility: MBBS Job Location : Delhi Last Date : 15-05-2013 Hiring Process : Walk-In.1 week ago -
Double Your Money in No Time Flat
—
Authority:
If youre looking to double your money, the biotech sector is one of the best hunting grounds that youll find. So far this year, for instance, the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) - an ETF thats a great proxy for the sector - has zoomed 28.2%, more than double the 13.59% SPDR S&P 500 ...1 week ago -
Double Your Money in No Time Flat
—
Authority:
If youre looking to double your money, the biotech sector is one of the best hunting grounds that youll find. So far this year, for instance, the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) - an ETF thats a great proxy for the sector - has zoomed 28.2%, more than double the 13.59% SPDR S&P 500 ...1 week ago -
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX®; Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD
—
Authority:
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 10, 2013.1 week ago -
Comments on Rapamycin and Metformin
—
Authority:
Three of the better known efforts to create a drug that modestly slows the rate of aging are centered on the following items: Resveratrol analogs that target sirtuins Rapamycin analogs that target mTOR Metformin Of these, ways to manipulate the activity of sirtuins have received the greatest attention ...1 week ago -
Cramer: Biotech Makes a Comeback
—
Authority:
Editors Note: This article was originally published on Real Money at 12:52 p.m. EDT on May 10. To see Jim Cramers latest commentary as its published, sign up for a free trial of Real Money. NEW YORK (Real Money) -- So, Celgene , Regeneron , Biogen Idec and Alexion rested, recharged and now are returning to ...1 week ago -
Healthcare Review: Sirona Dental Systems, Rosetta Genomics, Optimer Pharmaceuticals, Repros Therapeutics, Progenics Pharmaceuticals
—
Authority:
U.S. stocks were little changed Friday, with Wall Street readying for a third week of gains, as Wall Street considered monetary easing and finance ministers started a two-day meeting.1 week ago -
The Deal: Bain, TPG Get Windfall With Quintiles IPO
—
Authority:
NEW YORK (TheDeal) -- Quintiles Transnational Holdings raised about $947 million for its private-equity backers including Bain Capital Partners and TPG Group as research services company held its public offering at $40, and then proceeded to rise. Shares were little changed Friday at $42.07 after gaining 5.3% on ...1 week ago -
Nanomedicine Hits the Spot
—
Authority:
Advances in MedicineDan Peer, who runs a laboratory of nanomedicine at Tel Aviv University, says: “We have been hearing about the promise of nanomedicine for a long time, but it is now really starting to move.” Photo Credit & Source: Tel Aviv UniversityA Reuters article published in News Daily looks ...1 week ago -
ILRI PhotoBlog — ‘Livestock Portraits’: Sheko cattle in Ethiopia
—
Authority:
Sheko calf kept in the Ghibe Valley of Southern Ethiopia (photo credit: Jim Richardson) The above photo, taken by National Geographic photographer Jim Richardson , is of a Sheko calf kept in the Ghibe Valley of southern Ethiopia. The Sheko cattle breed is endangered, with only about 2,500 in existence today. They ...1 week ago -
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs
—
Authority:
Luke Timmerman [ Updated: 10:25 pm ET ] Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure five years after it was acquired by Japan-based Takeda Pharmaceuticals. Dunsire exits as the company is seeking to merge operations ...1 week ago -
Rockwell Medical Set to Disrupt Dialysis Treatment With New Drugs, DaVita Deal
—
Authority:
Sarah Schmid In the late 1990s, Wixom, MI-based Rockwell Medical revolutionized the dialysis industry by being the first to develop, patent, and bring to market a dry acid mixing system for hemodialysis concentrate. It eliminated the need for the bulky 55-gallon drums that were the industry standard at the time. ...1 week ago -
In-Potentia, from foreskin cells to biological brain
—
Authority:
Image courtesy "Where DogsRun" Its been too long since ive blogged about a project supported by Symbiotica (although they did get their fair amount of mentions and praises in #A.I.L., the show i present on ResonanceFM .) The new project -developed by researcher and artist Guy Ben-Ary and by artist and ...1 week ago -
Dendreon Shares Fall Again, as Provenge Sales Slump
—
Authority:
Luke Timmerman Dendreon has made a habit of disappointing investors, and it did so again today. The Seattle-based biotech company (NASDAQ: DNDN ) said today it generated $67.6 million in first quarter sales of sipuleucel-T (Provenge), down a whopping 17.6 percent from the $82 million in sales it reported for ...1 week ago -
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More
—
Authority:
Bruce V. Bigelow Amid the hectic pace of earnings releases, we saw a number of partnership agreements and other developments coming out of San Diego’s life sciences community. Here’s my wrap-up. —Shares of San Diego-based Receptos (NASDAQ: RCPT ), a biotech developing new treatments for immune ...1 week ago -
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up
—
Authority:
Bernadette Tansey At one edge of the sprawling Texas Medical Center in south central Houston, near a slew of hospitals and research hubs including the renowned MD Anderson Cancer Center, three floors of an office tower are reserved to nurture startup companies. The incubator is one of the initiatives that have ...1 week ago -
Assistant Clinical Professor of Law - University of Connecticut - Hartford, Conn.
—
Authority:
The University of Connecticut School of Law solicits applicationsfor an assistant clinical professor of law to serve as Director of theIntellectual Property and Entrepreneurship Law Clinic beginning August 1, 2013. The position is subject to the Law Schools policy on long-term renewablecontracts for clinical ...1 week ago -
Nimbus, Shire Partner on Rare Genetic Disease Drug Discovery
—
Authority:
(James. J. Caras, National Science Foundation) Nimbus Discovery , a biotechnology company in Cambridge, Massachusetts will discover and develop new small-molecule drug candidates to treat a set of rare genetic disorders, for the specialty pharmaceutical company Shire plc based in Ireland. Under the deal, Shire ...1 week ago -
#Tomorrow13 #BDSfail Hawking trip cancellation a hoax
—
Authority:
In a previous post, I reported that physicist Stephen Hawking is boycotting Israel by withdrawing from the Presidents Conference. That made me wonder whether Hawking would at least be morally consistent and extend his boycott to the company with the most advanced breakthrough for ALS, the disease from which he ...1 week ago


Follow Technorati